Literature DB >> 28978963

Editorial: Deep Remission in Eosinophilic Esophagitis With Long-Term Steroids: Difficult to Attain and Maintain.

Jeffrey Alexander1.   

Abstract

The study by Greuter et al. entitled "Long-term treatment of eosinophilic esophagitis and swallowed topical corticosteroids: development and evaluation of a therapeutic concept" follows 351 patients over 6 years. This gives considerable insight into long-term topical steroid management of EoE and establishes the concept of deep remission in EoE.

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28978963     DOI： 10.1038/ajg.2017.267

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN： 0002-9270            Impact factor:   10.864


  9 in total

1.  Long-term budesonide maintenance treatment is partially effective for patients with eosinophilic esophagitis.

Authors:  Alex Straumann; Sebastien Conus; Lukas Degen; Cornelia Frei; Christian Bussmann; Christoph Beglinger; Alain Schoepfer; Hans-Uwe Simon
Journal:  Clin Gastroenterol Hepatol       Date:  2011-01-28       Impact factor: 11.382

2.  Long-Term Treatment of Eosinophilic Esophagitis With Swallowed Topical Corticosteroids: Development and Evaluation of a Therapeutic Concept.

Authors:  Thomas Greuter; Christian Bussmann; Ekaterina Safroneeva; Alain M Schoepfer; Luc Biedermann; Stephan R Vavricka; Alex Straumann
Journal:  Am J Gastroenterol       Date:  2017-07-18       Impact factor: 10.864

3.  The Endoscopic Reference Score shows modest accuracy to predict histologic remission in adult patients with eosinophilic esophagitis.

Authors:  B D van Rhijn; J Verheij; A J P M Smout; A J Bredenoord
Journal:  Neurogastroenterol Motil       Date:  2016-06-02       Impact factor: 3.598

4.  Budesonide is effective in adolescent and adult patients with active eosinophilic esophagitis.

Authors:  Alex Straumann; Sebastien Conus; Lukas Degen; Stephanie Felder; Mirjam Kummer; Hansjürg Engel; Christian Bussmann; Christoph Beglinger; Alain Schoepfer; Hans-Uwe Simon
Journal:  Gastroenterology       Date:  2010-08-01       Impact factor: 22.682

5.  Delay in diagnosis of eosinophilic esophagitis increases risk for stricture formation in a time-dependent manner.

Authors:  Alain M Schoepfer; Ekaterina Safroneeva; Christian Bussmann; Tanja Kuchen; Susanne Portmann; Hans-Uwe Simon; Alex Straumann
Journal:  Gastroenterology       Date:  2013-08-13       Impact factor: 22.682

6.  The Endoscopic Reference Score shows modest accuracy to predict either clinical or histological activity in adult patients with eosinophilic oesophagitis.

Authors:  J Rodríguez-Sánchez; J Barrio-Andrés; O Nantes Castillejo; E Valdivieso-Cortazar; I Pérez-Martínez; A Boumidi; J A Olmos-Jérez; G Payeras-Llodra; N Alcaide-Suarez; L Ruiz-Rebollo; B Madrigal-Rubiales; E Gonzalez-Obeso; E de la Santa Belda; B López Viedma; J Molina-Infante
Journal:  Aliment Pharmacol Ther       Date:  2016-11-20       Impact factor: 8.171

7.  Endoscopic Mucosal Impedance Measurements Correlate With Eosinophilia and Dilation of Intercellular Spaces in Patients With Eosinophilic Esophagitis.

Authors:  David A Katzka; Karthik Ravi; Debra M Geno; Thomas C Smyrk; Prasad G Iyer; Jeffrey A Alexander; Jerry E Mabary; Michael Camilleri; Michael F Vaezi
Journal:  Clin Gastroenterol Hepatol       Date:  2015-01-13       Impact factor: 11.382

8.  Evaluation of Histologic Cutpoints for Treatment Response in Eosinophilic Esophagitis.

Authors:  W Asher Wolf; Cary C Cotton; Daniel J Green; Julia T Hughes; John T Woosley; Nicholas J Shaheen; Evan S Dellon
Journal:  J Gastroenterol Hepatol Res       Date:  2015-10-21

9.  A randomised, double-blind trial comparing budesonide formulations and dosages for short-term treatment of eosinophilic oesophagitis.

Authors:  Stephan Miehlke; Petr Hruz; Michael Vieth; Christian Bussmann; Ulrike von Arnim; Monther Bajbouj; Christoph Schlag; Ahmed Madisch; Christiane Fibbe; Henning Wittenburg; Hans Dieter Allescher; Max Reinshagen; Stefan Schubert; Jan Tack; Michaela Müller; Patrick Krummenerl; Joris Arts; Ralph Mueller; Karin Dilger; Roland Greinwald; Alex Straumann
Journal:  Gut       Date:  2015-03-19       Impact factor: 23.059
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.